Ledger.Open graph →
SEC Form D · filed January 5, 2022

Spotlight Therapeutics, Inc

Offering
$65.0M
Sold
$32.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Hayward, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Alexander D. Marson · Hayward, CADirectorPatrick D. Hsu · Hayward, CADirectorMary Haak-Frendscho · Hayward, CAExecJacob Corn · Hayward, CADirectorKrishna D. Yeshwant · Hayward, CADirectorAnthony Perera · Plantation, FLExecBrian Mark · Fort Lauderdale, FLDirectorScott Auker · Fort Lauderdale, FLDirectorEcho Street Capital Advisors LLC · New York, NYDirectorBrian P. Mcmanamon · Westlake, OHExecRobert C. Mcmanamon · Westlake, OHDirectorYvon J. Roy · Montreal, Quebec, CanadaDirectorMichael D. Schmalzbach · Miami Beach, FLDirectorKrishna D. Yeshwant · Hayward, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗